#hif-inhibitor — top 20, last 14d
| 0 | 💬 0 |
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.
(nejm.org)
|
New England Journal of Medicine 2026-07-02 | #immunotherapy #carcinoma #clinical trial #adjuvant #hif-inhibitor |